首页> 外文期刊>Materials science & engineering >In vitro and in vivo evaluation of bioglass microspheres incorporated brushite cement for bone regeneration
【24h】

In vitro and in vivo evaluation of bioglass microspheres incorporated brushite cement for bone regeneration

机译:掺入透钙磷石水泥的生物玻璃微球的体外和体内评价

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Bioglass-calcium phosphate cement (CPC) composite materials have recently received increased attention for bone regeneration purposes, owing to their improved properties in term of biocompatibility and bone ingrowths. In this study, an injectable bone substitute (IBS) system which utilizes bioglass microspheres incorporated into brushite based cement, was evaluated. The microspheres were synthesized with a simple and low sintering temperature process; there was no significant phase difference shown from the powder and good interactivity with cells was obtained. Furthermore, physical properties were optimized in microsphere incorporated brushite cement in order to investigate in vitro and in vivo performance. Accordingly, setting time and compressive strength were hardly altered until a microsphere content of 40% (v/v) was reached. The brushite (BR)/bioglass microsphere (BM) system showed excellent bioactivity to the in-vitro simulated body fluid test: dissolution ions from composite materials influenced apatite growth, countered acidic pH, and increased material degradation. In an in-vitro study with preosteoblasts (MC3T3-E1), BR/BM supported cell adhesion and proliferation, while cell differentiation experiments without osteogenic supplements, demonstrated that BR/BM induced osteogenic differentiation. A post-implantation study conducted in femoral defects showed higher materials degradation and bone formation in BR/BM than in BR. The faster dissolution of bioglass microspheres increased BR/BM composite resorption and hence facilitated bone tissue integration. Our findings suggest that bioglass microspheres incorporated in cement could potentially be used as an injectable bone substitute for bone regeneration applications.
机译:生物玻璃-磷酸钙水泥(CPC)复合材料由于其在生物相容性和骨骼向内生长方面的改进特性,最近因骨再生目的而受到越来越多的关注。在这项研究中,评估了将生物玻璃微球掺入透钙磷石基水泥中的可注射骨替代物(IBS)系统。通过简单且低烧结温度的方法合成了微球。从粉末没有显示出明显的相差,并且获得了与细胞的良好相互作用。此外,在掺入微球的透钙磷石水泥中优化了物理性能,以研究体外和体内性能。因此,直到达到40%(v / v)的微球含量,凝固时间和抗压强度几乎不变。透钙磷石(BR)/生物玻璃微球(BM)系统在体外模拟体液测试中显示出出色的生物活性:复合材料中的溶解离子影响磷灰石的生长,抵抗酸性pH并增加材料降解。在一项关于成骨细胞(MC3T3-E1)的体外研究中,BR / BM支持细胞黏附和增殖,而没有成骨作用的细胞分化实验表明,BR / BM可以诱导成骨分化。对股骨缺损进行的植入后研究显示,与BR相比,BR / BM的材料降解和骨形成更高。生物玻璃微球的更快溶解增加了BR / BM复合物的吸收,从而促进了骨组织的整合。我们的发现表明,掺入水泥中的生物玻璃微球有可能被用作骨再生应用的可注射骨替代物。

著录项

  • 来源
    《Materials science & engineering》 |2019年第10期|109775.1-109775.12|共12页
  • 作者单位

    Soonchunhyang Univ, Coll Med, Dept Regenerat Med, 366-1 Ssangyong Dong, Cheonan 330090, Chungcheongnam, South Korea;

    Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, 366-1 Ssangyong Dong, Cheonan 330090, Chungcheongnam, South Korea;

    Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, 366-1 Ssangyong Dong, Cheonan 330090, Chungcheongnam, South Korea;

    Soonchunhyang Univ, Coll Med, Dept Regenerat Med, 366-1 Ssangyong Dong, Cheonan 330090, Chungcheongnam, South Korea;

    Soonchunhyang Univ, Coll Med, Dept Regenerat Med, 366-1 Ssangyong Dong, Cheonan 330090, Chungcheongnam, South Korea;

    Soonchunhyang Univ, Coll Med, Dept Regenerat Med, 366-1 Ssangyong Dong, Cheonan 330090, Chungcheongnam, South Korea|Soonchunhyang Univ, Coll Med, Inst Tissue Regenerat, 366-1 Ssangyong Dong, Cheonan 330090, Chungcheongnam, South Korea;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Injectable bone substitute; Bioglass microspheres; Brushite; Biocompatibility;

    机译:可注射骨替代;生物胶质微球;血管石;生物相容性;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号